Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid

Published:2015-11-13 Issue:5 Volume:174 Page:820-822
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhu Hong-Hu¹,Wu De-Pei²,Jin Jie³,Li Jian-Yong⁴,Ma Jun⁵,Wang Jian-Xiang⁶,Chen Sai-Juan⁷,Huang Xiao-Jun¹

Affiliation:

1. Peking University People's Hospital; Beijing China

2. First Affiliated Hospital of Soochow University; Suzhou Jiangsu China

3. First Affiliated Hospital of Zhejiang University; Hangzhou Zhejiang China

4. First Affiliated Hospital of Nanjing Medical University; Jiangsu Province Hospital; Nanjing China

5. Harbin Institute of Haematology and Oncology; Harbin China

6. Institute of Haematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Tianjin China

7. Rui Jin Hospital affiliated with Shanghai Jiao Tong University School of Medicine; Shanghai China

Funder

National High-Tech R&D (863) Programme

National Natural Science Foundation of China

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13809/fullpdf

Reference10 articles.

1. Targeting agents alone to cure acute promyelocytic leukemia;Chen;New England Journal of Medicine,2013

2. Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia;Estey;Blood,2006

3. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxidebased therapy in newly diagnosed acute promyelocytic leukemia;Hu;Proceedings of the National Academy of Sciences of the United States of America,2009

4. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acutepromyelocytic leukemia (APML4);Iland;Blood,2012

5. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia;Lo-Coco;New England Journal of Medicine,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. At What Point Are Long-Term (>5 Years) Survivors of APL Safe? A Study from the SEER Database;Cancers;2023-01-17

2. Pharmacology, Toxicology, and Rational Application of Cinnabar, Realgar, and Their Formulations;Evidence-Based Complementary and Alternative Medicine;2022-09-27

3. Oral Realgar-Indigo Naturalis Formula Treatment for Acute Promyelocytic Leukemia in Children: A Randomized, Control Clinical Trial;Evidence-Based Complementary and Alternative Medicine;2022-07-05

4. Prospect of research and clinical application of arsenic compounds in chemotherapy for gynecological malignant tumors;Gynecology and Obstetrics Clinical Medicine;2022-03

5. Successful treatment of acute promyelocytic leukemia in a 92-year-old man using all-trans retinoic acid combined with oral arsenic;Medicine;2021-06-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3